Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | - | - |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 2.42 | 0.94 |
NAV | ₹14.13 | ₹69.81 |
Fund Started | 03 Jan 2020 | 29 Jan 2005 |
Fund Size | ₹61.70 Cr | ₹95.79 Cr |
Exit Load | For units in excess of 12% of the investment,1% will be charged for redemption within 365 Days. | Exit load of 0.25% if redeemed within 1 month |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 6.11% | 8.67% |
3 Year | 12.21% | 23.43% |
5 Year | 14.31% | 25.09% |
1 Year
3 Year
5 Year
Equity | 93.94% | 98.48% |
Cash | 6.06% | 1.51% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
ICICI Bank Ltd. | 7.84% |
Kotak Mahindra Bank Ltd. | 7.69% |
JSW Steel Ltd. | 7.11% |
Wipro Ltd. | 6.85% |
Indraprastha Gas Ltd. | 6.66% |
Biocon Ltd. | 6.57% |
UPL Ltd. | 5.38% |
HDFC Bank Ltd. | 4.60% |
PB Fintech Ltd. | 4.51% |
Info Edge (India) Ltd. | 4.29% |
Name | Assets |
---|---|
ICICI Bank Ltd. | 8.94% |
HDFC Bank Ltd. | 8.24% |
Reliance Industries Ltd. | 5.50% |
Larsen & Toubro Ltd. | 4.71% |
State Bank of India | 4.36% |
Bharti Airtel Ltd. | 3.70% |
Mahindra & Mahindra Ltd. | 3.36% |
Infosys Ltd. | 3.13% |
Bharat Electronics Ltd. | 3.12% |
Sun Pharmaceutical Industries Ltd. | 3.06% |
Name | Sailesh Jain | Akshay Sharma |
Start Date | 16 Dec 2021 | 01 Dec 2022 |
Name
Start Date
Description | The scheme seeks to generate medium to long-term capital appreciation by investing in equity and equity related instruments selected based on a quantitative model (Quant Model). | The Scheme seeks to generate capital appreciation through investment in equity and equity related instruments. The Scheme will seek to generate capital appreciation by investing in an active portfolio of stocks selected on the basis of a Quant model. |
Launch Date | 03 Jan 2020 | 29 Jan 2005 |
Description
Launch Date